Hospital stocks attractive as potential regulation impact to stay under 10%, says Elara Securities
The Supreme Court recently advocated for a 16 percent margin cap on drugs, triggering a sharp sell-off in healthcare counters. However, Elara Securities believes the sector's overall profitability should be viewed in its entirety and valuations have turned favourable for medium-term investors.
The Supreme Court recently advocated for a 16 percent margin cap on drugs, triggering a sharp sell-off in healthcare counters. However, Elara Securities believes the sector's overall profitability should be viewed in its entirety and valuations have turned favourable for medium-term investors.
What's Your Reaction?
